Occupational Therapists in Danville, IL Accepting Medicare
9 Occupational Therapists found. Showing 1 - 9
 Dr. Jennifer Aileen Reedy, OTD Occupational Therapist - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1900 E Main St, Danville, IL 61832 Phone: 217-766-4933 |
Mrs. Debra Sue Taulman, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1021 Brewer Rd, Danville, IL 61834 Phone: 217-597-6560 Fax: 203-547-6560 |
 Mr. Andrew R Turner, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3733 Poolside Dr, Danville, IL 61832 Phone: 217-442-0812 Fax: 217-442-2181 |
Brett Jacobs Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 E Main St, Danville, IL 61832 Phone: 217-554-5598 Fax: 217-554-5598 |
Stacey Lea Henson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Warrington Ave, Danville, IL 61832 Phone: 217-446-0660 |
Mr. Eric Lydel Miller, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 East Main, Danville, IL 61832 Phone: 217-554-3000 |
Amber Leann Vedder-reid, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3222 Independence Dr, Danville, IL 61832 Phone: 217-431-1600 |
Ms. Michelle Hein, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3733 Poolside Dr, Danville, IL 61832 Phone: 217-326-2911 Fax: 217-344-8047 |
Gary Alan Vanhuysen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 E Main St, Danville, IL 61832 Phone: 217-554-5243 |
News Archive
United Therapeutics submits pre-market approval application for use of Remodulin with implantable drug infusion system
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
Researcher presents proposals designed to address affective-sexual diversity in school environments
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Preclinical study results for Syk, JAK inhibitor program presented at ASH 2010
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Acticoat Flex dressings with NUCRYST's SILCRYST nanocrystalline silver coatings launched in Europe
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and the Advanced Wound Management division of Smith Nephew plc announced today the European launch of Acticoat(TM) Flex3 and Acticoat(TM) Flex7. The Flex range is the newest addition to the Acticoat(TM) portfolio of dressings with NUCRYST's proprietary SILCRYST(TM) nanocrystalline silver coatings.
› Verified 3 days ago
Physical Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Occupational Therapists
Podiatrists
Audiologists